• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Clarivate Plc filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits

    5/12/25 4:46:05 PM ET
    $CLVT
    EDP Services
    Technology
    Get the next $CLVT alert in real time by email
    false 0001764046 00-0000000 0001764046 2025-05-07 2025-05-07 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

     

    Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

     

    Date of Report (Date of earliest event reported): May 12, 2025 (May 7, 2025)

     

    CLARIVATE PLC 

    (Exact name of registrant as specified in its charter)

     

    Jersey, Channel Islands

    (State or other jurisdiction of incorporation or organization)

     

    001-38911 N/A
    (Commission File Number) (I.R.S Employer Identification No.)

     

    70 St. Mary Axe

    London EC3A 8BE
    United Kingdom

    (Address of Principal Executive Offices)(Zip Code)

     

    (44) 207-433-4000

    (Registrant’s Telephone Number, Including Area Code)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

     

    ¨Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

     

    ¨Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

     

    ¨Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

     

    ¨Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

     

    Securities registered pursuant to Section 12(b) of the Exchange Act:

     

    Title of each class   Trading symbol(s)   Name of each exchange on which registered
    Ordinary shares, no par value   CLVT   New York Stock Exchange

     

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

     

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

     

     

     

     

     

    Item 5.07.Submission of Matters to a Vote of Security Holders

     

    On May 7, 2025, Clarivate Plc (“Clarivate” or the “Company”) held its 2025 Annual General Meeting of Shareholders.

     

    At that meeting, the shareholders considered and acted upon five proposals pursuant to the Notice of Annual General Meeting of Shareholders and as described in more detail in the Company’s definitive proxy statement dated March 28, 2025 (the “Proxy Statement”).

     

    Of 688,956,113 ordinary shares outstanding and entitled to vote as of March 10, 2025 (the “Record Date”), the holders of 659,171,835 ordinary shares were present at the meeting either in person or by proxy, constituting a quorum.

     

    All proposals on the agenda were approved by the shareholders.

     

    Below are the final voting results. In tabulating the voting results, only FOR or AGAINST votes are counted. Broker non-votes and abstentions are counted only for purposes of determining whether a quorum is present.

     

    Proposal 1: Election of Directors

     

    Shareholders elected the individuals named below to serve as directors of the Company, until the Company’s 2026 Annual General Meeting, or until their successor is duly elected and qualified, or their earlier resignation or removal. Election of each director required approval by a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    Nominee   For   Against   Abstain   Broker Non-Votes
    Andrew Snyder   609,288,151   18,870,707   10,850,539   20,162,438
    Valeria Alberola   626,579,233   1,520,744   10,909,420   20,162,438
    Jane Okun Bomba   620,888,626   7,198,642   10,922,129   20,162,438
    Usama N. Cortas   623,801,935   4,311,807   10,895,655   20,162,438
    Suzanne Heywood   595,610,135   32,401,139   10,998,123   20,162,438
    Adam T. Levyn   623,280,366   4,831,503   10,897,528   20,162,438
    Anthony Munk   614,965,624   13,121,612   10,922,161   20,162,438
    Wendell Pritchett   609,866,189   18,256,676   10,886,532   20,162,438
    Saurabh Saha   625,048,677   3,037,993   10,922,727   20,162,438
    Matitiahu (Matti) Shem Tov   626,794,091   1,228,642   10,986,664   20,162,438

     

     

     

     

    Proposal 2: Advisory Approval of Executive Compensation

     

    Shareholders approved, on an advisory, non-binding basis, the compensation of the Company’s named executive officers as disclosed in the Proxy Statement. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    619,205,075   8,950,331   10,853,991   20,162,438

     

    Proposal 3: Ratification of Appointment of Independent Registered Public Accountants

     

    Shareholders reappointed PricewaterhouseCoopers LLP as the Company’s auditors, ratified their appointment as the Company’s independent registered public accountants for the fiscal year 2025 on a non-binding and advisory basis, and authorized the Company’s Board of Directors, acting through its Audit Committee, to determine the fees to be paid to the auditors. Ratification required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    645,344,218   2,868,670   10,958,947   —

     

    Proposal 4: Approval of the Clarivate Plc Amended and Restated 2019 Incentive Award Plan

     

    Shareholders approved the Clarivate Plc Amended and Restated 2019 Incentive Award Plan. Approval required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    558,462,654   69,708,837   10,837,906   20,162,438

     

    Proposal 5: Authorization to Repurchase the Company’s Ordinary Shares in Open-Market Transactions

     

    Shareholders authorized the Company to conduct open-market purchases of its ordinary shares from time to time as approved by the Board of Directors. The first resolution pursuant to Proposal 5 was approved as a special resolution that required at least two-thirds of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy. The second resolution pursuant to Proposal 5 was an ordinary resolution that required a simple majority of the votes cast by, or on behalf of, the shareholders entitled to vote in person or represented by proxy.

     

    For   Against   Abstain   Broker Non-Votes
    627,212,208   676,681   11,120,508   20,162,438

     

    Item 8.01.Other Events

     

    Date of 2026 Annual General Meeting of Shareholders

     

    Clarivate’s 2026 Annual General Meeting of Shareholders will be held on May 14, 2026. Further details will be provided in the proxy statement for the meeting.

     

    Item 9.01. Financial Statements and Exhibits

     

    (d) Exhibits

     

    No. Description
    104 Cover page of this Current Report on Form 8-K formatted in Inline XBRL

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

      CLARIVATE PLC
         
    Date: May 12, 2025 By: /s/ John Doulamis
      Name: John Doulamis
      Title: Senior Vice President and General Counsel

     

     

     

    Get the next $CLVT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $CLVT

    DatePrice TargetRatingAnalyst
    11/6/2024Outperform → Mkt Perform
    William Blair
    12/15/2023$8.00Equal Weight → Underweight
    Wells Fargo
    10/16/2023$10.00 → $8.50Hold → Buy
    Jefferies
    9/8/2023$8.00 → $7.00Equal Weight → Underweight
    Barclays
    8/25/2023$9.00 → $8.00Outperform → Sector Perform
    RBC Capital Mkts
    8/7/2023$10.00 → $6.00Neutral → Underperform
    BofA Securities
    8/4/2023$15.00 → $8.00Overweight → Equal Weight
    Wells Fargo
    6/13/2023$11.00Outperform
    Oppenheimer
    More analyst ratings

    $CLVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Bomba Jane L Okun was granted 6,686 units of Ordinary Shares and covered exercise/tax liability with 306 units of Ordinary Shares, increasing direct ownership by 3% to 213,670 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:41 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Snyder Andrew Miles was granted 11,918 units of Ordinary Shares and covered exercise/tax liability with 527 units of Ordinary Shares, increasing direct ownership by 7% to 164,489 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:30 PM ET
      $CLVT
      EDP Services
      Technology
    • President, IP Samson James Gordon sold $453,000 worth of Ordinary Shares (100,000 units at $4.53), decreasing direct ownership by 7% to 1,271,103 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      7/2/25 4:27:20 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Snyder Andrew Miles bought $989,024 worth of Ordinary Shares (237,176 units at $4.17) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/18/25 4:56:10 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Bomba Jane L Okun bought $200,492 worth of Ordinary Shares (49,750 units at $4.03) (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/14/25 4:14:29 PM ET
      $CLVT
      EDP Services
      Technology
    • Director Pritchett Wendell E. bought $100,114 worth of Ordinary Shares (22,857 units at $4.38), increasing direct ownership by 47% to 71,835 units (SEC Form 4)

      4 - CLARIVATE PLC (0001764046) (Issuer)

      3/5/25 4:17:24 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    SEC Filings

    See more
    • Clarivate Plc filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      6/2/25 8:45:15 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Plc filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

      8-K - CLARIVATE PLC (0001764046) (Filer)

      5/19/25 4:49:39 PM ET
      $CLVT
      EDP Services
      Technology
    • Amendment: SEC Form SCHEDULE 13G/A filed by Clarivate Plc

      SCHEDULE 13G/A - CLARIVATE PLC (0001764046) (Subject)

      5/14/25 4:29:43 PM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Clarivate downgraded by William Blair

      William Blair downgraded Clarivate from Outperform to Mkt Perform

      11/6/24 8:22:43 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate downgraded by Wells Fargo with a new price target

      Wells Fargo downgraded Clarivate from Equal Weight to Underweight and set a new price target of $8.00

      12/15/23 8:04:33 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate upgraded by Jefferies with a new price target

      Jefferies upgraded Clarivate from Hold to Buy and set a new price target of $8.50 from $10.00 previously

      10/16/23 9:11:50 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Clarivate to Report Second Quarter 2025 Results on July 30, 2025

      LONDON, July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, July 30, 2025 to review the results. The webcast is open to all interest

      7/8/25 7:30:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Unveils the 2025 Journal Citation Reports

      50th Anniversary Year Sees Strengthened Focus on Research Integrity LONDON, June 18, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today released the 2025 update to the Journal Citation Reports (JCR). This is the 50th anniversary of the industry-leading annual reports, which provide a comprehensive overview of the world's leading and trusted academic journals, offering academic institutions, researchers, and publishers the ability to gauge journals' trustworthiness and impact. Only journals that have met the rigorous

      6/18/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Partners with American Library Association to Advocate for U.S. Libraries

      LONDON, June 9, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, today announced a new milestone in its decades-long partnership with the American Library Association (ALA). Clarivate will be the first sponsor of the ALA Public Supporter Program, which engages the public in supporting libraries and library professionals.   The ALA is the largest library association in the world. It advocates for libraries, library workers, and everyone they serve, from small, rural libraries to the largest library systems in the country.

      6/9/25 3:00:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Leadership Updates

    Live Leadership Updates

    See more
    • Clarivate Appoints Henry Levy as President, Life Sciences & Healthcare

      Concludes the appointments for business leaders of its three market segments LONDON, April 26, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, announced today that it has appointed Henry Levy as President, Life Sciences & Healthcare, effective May 1, 2023. Henry joins from Veeva Systems, a global leader in cloud software for the life sciences industry, where he most recently served as President, Global R&D and Quality, with responsibility for driving sales across the segment. Jonathan Gear,

      4/26/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Names Bar Veinstein as President, Academia & Government

      Appointing the second of three business leaders for its newly created market segments LONDON, April 19, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Bar Veinstein will join the company as President, Academia & Government, effective April 24, 2023. Bar joins from Taranis, an AI-powered crop intelligence provider, where he was Chief Executive Officer focusing on driving business growth, improving customer satisfaction and accelerating the company's artificial intelligence (AI) strategy. He previously spent 11 years with the Ex Libris Group, now part of Clarivate, and under his leader

      4/19/23 7:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Announces Gordon Samson as President, Intellectual Property and Nominates Dr. Saurabh Saha as New Independent Director

      Naming the first of three business leaders for its newly created market segments and nominating new Independent Director to its Board LONDON, March 23, 2023 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust, today announced that Gordon Samson, currently Chief Product Officer, has been appointed President of its Intellectual Property (IP) market segment, effective April 1. The Company also announced that it has nominated Dr. Saurabh Saha to stand for election as a director at its 2023 Annual General Meeting of shareholders on May 4, 2023.

      3/23/23 4:30:00 PM ET
      $CLVT
      $CNTA
      EDP Services
      Technology
      Biotechnology: Pharmaceutical Preparations
      Health Care

    $CLVT
    Financials

    Live finance-specific insights

    See more
    • Clarivate to Report Second Quarter 2025 Results on July 30, 2025

      LONDON, July 8, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the second quarter 2025 before the market opens on Wednesday, July 30, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Wednesday, July 30, 2025 to review the results. The webcast is open to all interest

      7/8/25 7:30:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate Reports First Quarter 2025 Results

      — Accelerated recurring organic revenue growth — — Reaffirmed 2025 Outlook — — Repurchased $50 million ordinary shares — LONDON, April 29, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today reported results for the first quarter ended March 31, 2025. Total revenues for the first quarter of 2025 was $593.7 million, compared to total revenues of $621.2 million for the first quarter of 2024. Organic revenues for the first quarter of 2025 increased 0.3%, compared to the first quarter of 202

      4/29/25 6:00:00 AM ET
      $CLVT
      EDP Services
      Technology
    • Clarivate to Report First Quarter 2025 Results on April 29, 2025

      LONDON, April 2, 2025 /PRNewswire/ -- Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, announced today it will report its financial results for the first quarter 2025 before the market opens on Tuesday, April 29, 2025. The press release and earnings supplement, with accompanying financial information, will be available on the Clarivate investor website at https://ir.clarivate.com. The Company will host a conference call and webcast at 9:00 AM Eastern Time on Tuesday, April 29, 2025 to review the results. The webcast is open to all interested

      4/2/25 8:05:00 AM ET
      $CLVT
      EDP Services
      Technology

    $CLVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • Amendment: SEC Form SC 13G/A filed by Clarivate Plc

      SC 13G/A - CLARIVATE PLC (0001764046) (Subject)

      12/5/24 10:02:09 AM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13G filed by Clarivate Plc

      SC 13G - CLARIVATE PLC (0001764046) (Subject)

      11/13/24 4:18:30 PM ET
      $CLVT
      EDP Services
      Technology
    • SEC Form SC 13D/A filed by Clarivate Plc (Amendment)

      SC 13D/A - CLARIVATE PLC (0001764046) (Subject)

      3/4/24 9:01:44 AM ET
      $CLVT
      EDP Services
      Technology